anti-microbial Archives · BioBuzz

“In Conversation” with Mina Izadjoo, President of IPS

<img width="270" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2-270x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=54x60&lossy=1&strip=1&webp=1 54w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=108x120&lossy=1&strip=1&webp=1 108w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=162x180&lossy=1&strip=1&webp=1 162w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2.jpg?size=216x240&lossy=1&strip=1&webp=1 216w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/09/Mina-ISPE_HEADSHOTS_HIGH_RES-120-2-270x300.jpg?lossy=1&strip=1&webp=1 270w" sizes="(max-width: 270px) 100vw, 270px" />

Published on : September 5, 2018March 4, 2021 Published by : Sarah Ellinwood

“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

<img width="270" height="284" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3-270x284.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="Carol Nacy, Ph.D." decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3.jpg?size=128x135&lossy=1&strip=1&webp=1 128w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/08/Carol-Nacy-Headshot-3.jpg?lossy=1&strip=1&webp=1 270w" sizes="(max-width: 270px) 100vw, 270px" />

Published on : August 27, 2018September 20, 2021 Published by : Steven Surdez

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all [….]